These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1994682)

  • 41. Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials.
    Vimalachandra D; Craig JC; Cowell CT; Knight JF
    J Pediatr; 2001 Oct; 139(4):560-7. PubMed ID: 11598604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Haffner D; Schaefer F; Nissel R; Wühl E; Tönshoff B; Mehls O
    N Engl J Med; 2000 Sep; 343(13):923-30. PubMed ID: 11006368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic growth hormone administration does not suppress endogenous growth hormone secretion in patients with neurosecretory growth hormone dysfunction.
    Zadik Z; Limoni Y; Lieberman E
    Horm Res; 1991; 35(3-4):95-8. PubMed ID: 1806474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M; Hochberg Z
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term growth response to GH treatment and considerations upon the limits of short-term growth predictions.
    Hermanussen M; Gausche R; Keller A; Kiess W; Brabec M; Keller E
    Horm Res; 2002; 58(2):71-7. PubMed ID: 12207165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Final height gain by GH therapy in children with idiopathic short stature is dose dependent.
    Wit JM; Rekers-Mombarg LT;
    J Clin Endocrinol Metab; 2002 Feb; 87(2):604-11. PubMed ID: 11836292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can renal handling of phosphate predict response to growth hormone therapy in normal variant short children by short-term treatment?
    Tomoeda S; Nishiyama S; Nakamura T; Matsuda I
    Acta Paediatr; 1994 Jul; 83(7):736-40. PubMed ID: 7949804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of growth hormone therapy on final versus predicted height in short twelve- to sixteen-year-old boys without growth hormone deficiency.
    Kaplowitz PB
    J Pediatr; 1995 Mar; 126(3):478-80. PubMed ID: 7869214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term treatment with human growth hormone in children with non-growth hormone deficient short stature.
    Kaplan SL; Grumbach MM
    Acta Paediatr Jpn; 1988; 30 Suppl():35-8. PubMed ID: 3146874
    [No Abstract]   [Full Text] [Related]  

  • 51. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
    Haddy TB; Mosher RB; Nunez SB; Reaman GH
    Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant growth hormone for children and adolescents with Turner syndrome.
    Baxter L; Bryant J; Cave CB; Milne R
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003887. PubMed ID: 17253498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth and growth hormone secretion in children with cancer treated with chemotherapy.
    Roman J; Villaizán CJ; García-Foncillas J; Salvador J; Sierrasesúmaga L
    J Pediatr; 1997 Jul; 131(1 Pt 1):105-12. PubMed ID: 9255200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of clonidine and standard provocative agents of growth hormone.
    Slover RH; Klingensmith GJ; Gotlin RW; Radcliffe J
    Am J Dis Child; 1984 Mar; 138(3):314-7. PubMed ID: 6322574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation.
    Papadimitriou A; Urena M; Hamill G; Stanhope R; Leiper AD
    Arch Dis Child; 1991 Jun; 66(6):689-92. PubMed ID: 2053788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole body nitrogen kinetics and their relationship to growth in short children treated with recombinant human growth hormone.
    Dempsher DP; Bier DM; Tollefsen SE; Rotwein PS; Daughaday WH; Jensen MC; Galgani JP; Heath-Monnig E; Trivedi B
    Pediatr Res; 1990 Oct; 28(4):394-400. PubMed ID: 2235139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Criteria for recognition of the growth-inefficient child who may respond to treatment with growth hormone.
    Saggese G; Cesaretti G
    Am J Dis Child; 1989 Nov; 143(11):1287-93. PubMed ID: 2816855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intermittent recombinant growth hormone treatment in short children born small for gestational age: four-year results of a randomized trial of two different treatment regimens.
    Simon D; Leger J; Fjellestad-Paulsen A; Crabbé R; Czernichow P;
    Horm Res; 2006; 66(3):118-23. PubMed ID: 16772718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clonidine in the treatment of short stature: preliminary clinical experience].
    Calzolari G; Bellini M; Alboni S; Riva P; Bonati E
    G Clin Med; 1990; 71(8-9):517-20. PubMed ID: 2279627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.